Next-generation nanomedicines and nanosimilars: EU regulators’ initiatives relating to the development and evaluation of nanomedicines

Safety assessment of nanomaterials: Implications for nanomedicine

(2012) Andreas M. Nyström et al.   JOURNAL OF CONTROLLED RELEASE

Doxil® — The first FDA-approved nano-drug: Lessons learned

(2012) Yechezkel (Chezy) Barenholz   JOURNAL OF CONTROLLED RELEASE

FDA's Approach to Regulation of Products of Nanotechnology

(2012) M. A. Hamburg   SCIENCE

Nanomedicine(s) under the Microscope

(2011) Ruth Duncan et al.   MOLECULAR PHARMACEUTICS

Clinical Use of Intravenous Iron: Administration, Efficacy, and Safety

(2011) M. Auerbach et al.   Hematology-American Society of Hematology Education Program

Nanotechnology-Based Cancer Therapeutics—Promise and Challenge—Lessons Learned Through the NCI Alliance for Nanotechnology in Cancer

(2010) Dorothy Farrell et al.   PHARMACEUTICAL RESEARCH

Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release

(2010) Chris Oerlemans et al.   PHARMACEUTICAL RESEARCH

The therapeutic equivalence of complex drugs

(2010) Huub Schellekens et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications

(2009) Bengt Fadeel et al.   ADVANCED DRUG DELIVERY REVIEWS

Amphotericin B lipid preparations: what are the differences?

(2008) J.P. Adler-Moore et al.   CLINICAL MICROBIOLOGY AND INFECTION

Polymeric Micellar Delivery Systems in Oncology

(2008) Y. Matsumura   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Nanotoxicology and nanomedicine: making hard decisions

(2008) Igor Linkov et al.   Nanomedicine-Nanotechnology Biology and Medicine

Intravenous Iron, Inflammation, and Oxidative Stress: Is Iron a Friend or an Enemy of Uremic Patients?

(2007) Liliana Garneata   JOURNAL OF RENAL NUTRITION